Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH14755 in Dyslipidemia and Type II Diabetes
NCT02586129Phase 3Completed
- Sponsor
- Yuhan
- Start
- Nov 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin + metformin in dyslipidemia, type 2 diabetes mellitus (T2DM), sponsored by Yuhan. Started Nov 2015; status: completed.
02
Drugs
rosuvastatin + metformin
03
Conditions
dyslipidemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02586129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586129.